Concentrations (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Fair value, concentration of risk, cash and cash equivalents | $ 1,000,000 | $ 77,000 |
| Non-United States [Member] | ||
| Net assets | 1,722,758 | 161,839 |
| Intercompany receivables | $ 7,100,000 | $ 7,600,000 |
| Customer One [Member] | Accounts Receivable Net [Member] | ||
| Concentration risk percentage | 9.00% | 8.00% |
| Customer Two [Member] | Accounts Receivable Net [Member] | ||
| Concentration risk percentage | 5.00% | 7.00% |
| One Customer [Member] | Sales Revenue, Net [Member] | ||
| Concentration risk percentage | 10.00% | 10.00% |
| X | ||||||||||
- Definition Carrying value of amount of intercompany receivables as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Amount of net assets (liabilities). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This item represents disclosure of all significant concentrations of credit risk or market risk arising from the subject financial instrument (as defined), whether from an individual counterparty or groups of counterparties. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|